Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Lessons from antiamyloid-β immunotherapies in Alzheimer's disease — Germán Plascencia‐Villa (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Lessons from antiamyloid-β immunotherapies in Alzheimer's disease
Shared by
George Perry
Lessons from antiamyloid-β immunotherapies in Alzheimer's disease
Article
2023
en
Authors
GP
Germán Plascencia‐Villa
George Perry
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2000
How important is oxidative damage? Lessons from Alzheimer’s disease
George Perry
,
Arun K. Raina
,
Akihiko Nunomura
,
Takafumi Wataya
,
Lawrence M. Sayre
,
Mark A. Smith
Article
2023
MRI in the new era of antiamyloid mAbs for the treatment of Alzheimer's disease
Massimo Filippi
,
Giordano Cecchetti
,
Federica Agosta
Article
2021
Immune modulations and immunotherapies for Alzheimer’s disease: a comprehensive review
Sara Mahdiabadi
,
Sara Momtazmanesh
,
George Perry
,
Nima Rezaei
Article
2021
The Amyloid-β Pathway in Alzheimer’s Disease
Harald Hampel
,
John Hardy
,
Kaj Blennow
,
Christopher Chen
,
George Perry
,
Seung Hyun Kim
,
Victor L. Villemagne
,
Paul Aisen
,
Michele Vendruscolo
,
Takeshi Iwatsubo
,
Colin L. Masters
,
Min Cho
,
Lars Lannfelt
,
Jeffrey L. Cummings
,
Andrea Vergallo
Article
2005
Role of Amyloid‐β in Alzheimer's Disease
Mark A. Smith
,
George Perry
Discussion(0)
No comments yet. Be the first to comment.